• Down 32% in FY20, is the NAB share price a buy this year?

    Model of bank building on top of charts, bank shares, NAB share price, westpac share price

    The National Australia Bank Ltd. (ASX: NAB) share price slumped 32% lower in FY20, but is the ASX bank share a strong buy this year?

    Why did the NAB share price slump lower in FY20?

    It’s been a tough 12 months for all the ASX bank shares. While the S&P/ASX 200 Index (ASX: XJO) fell 11.3%, the NAB share price fell even further.

    The coronavirus pandemic has spooked investors and hit some bank shares harder than others in 2020. In fact, NAB’s value has slumped 24.5% lower this calendar year while Commonwealth Bank of Australia (ASX: CBA) shares are down just 12.5%.

    CommBank shares have been surging in value in recent weeks with the bank selling its 55% stake in Colonial First State for $1.7 billion in May.

    But NAB is far from alone as Westpac Banking Corp (ASX: WBC) shares remain down 34.5% in the last 12 months.

    There are still some looming questions about the housing market and economy in general. These factors are weighing on investors’ minds and the NAB share price as we enter FY21.

    NAB also slashed its dividend in April, announcing a 30 cents per share interim, fully franked dividend. Many investors were disappointed by the cut, down 64% from 1H 2019 distributions, combined with a $3.5 billion equity raise.

    But as we enter a new financial year, will we see strong prospects for the NAB share price and the bank’s investors?

    Can NAB surge in value this year?

    I personally think the market is at an interesting point right now. I’m keen to see what the impact will be on the ASX when the government starts rolling back stimulus measures from September.

    If the economy bounces back sooner than expected, the NAB share price could finish the year strongly. A robust housing market and lower than anticipated unemployment would be good news for ASX bank shares.

    However, that is far from a certainty at this point in time. NAB’s next earnings result is due in November but I wouldn’t be holding out for a big dividend given the current conditions.

    Having said that, long term, I still see the NAB share price as a strong buy for dividends.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Down 32% in FY20, is the NAB share price a buy this year? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2BV2n3N

  • Webjet share price on watch after boosting its liquidity

    Corporate travel jet flying into sunset

    The Webjet Limited (ASX: WEB) share price will be on watch on Thursday after it followed the lead of rival Flight Centre Travel Group Ltd (ASX: FLT) by bolstering its liquidity.

    What did Webjet announce?

    This morning the online travel agent announced the successful pricing of an offering of 100 million euros (A$163.1 million) convertible notes due in 2027.

    Webjet’s Managing Director, John Guscic, explained: “This Offering supports our ongoing focus on maintaining a strong balance sheet as we continue to navigate the challenging operating environment caused by COVID-19.”

    The chief executive expects the notes to diversify the company’s funding sources and increase its financial and strategic flexibility. He also believes it will put Webjet in a position to take advantage of any opportunities in the future.

    He added: “We continue to believe the strength of Webjet’s capital position in the current uncertain environment will provide a strategic advantage longer term, enabling the Company to execute its strategy and take advantage of opportunities as they arise.”

    What will the funds be used for?

    The company will use the proceeds to repay $50 million of its existing term debt, whilst extending remaining term debt maturity into late 2022. It will also use some of the proceeds for potential acquisitions and ongoing capital management.

    Though, management notes that there is no agreement or understanding with respect to any potential acquisitions or investments at this time.

    Trading update.

    Webjet also released a trading update with its offering. It advised that, as expected, its total transaction value (TTV) and revenue in April and May 2020 were nominal.

    And while the company has started to see some booking activity in its Australian OTA and WebBeds businesses, it expects any revenue contribution in the near term to only be modest.

    It also advised that its operating costs from April 2020 to the end of June 2020 were averaging $15 million month. This is a reduction of approximately $13 million per month from pre COVID-19 expenditure.

    Finally, on another note, Webjet has just announced an agreement with Afterpay Ltd (ASX: APT), which will see it offer customer buy now pay later options. It is available on flight, hotel, and package bookings up to $2,000.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Webjet share price on watch after boosting its liquidity appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31NbTRF

  • MARKETS: NASDAQ closes at record high, up 95 points — YF Premium is bullish on Micron Technologies (MU)

    MARKETS: NASDAQ closes at record high, up 95 points — YF Premium is bullish on Micron Technologies (MU)Yahoo Finance’s Jared Blikre joins Seana Smith to break down the day’s price action in stocks as well as a long in Micron Technologies (MU), a Yahoo Finance Premium Investment Idea.

    from Yahoo Finance https://ift.tt/31x9Z7r

  • Here are 2 quality ASX healthcare shares to buy in July

    asx healthcare shares, stethoscope on bar chart

    The ASX healthcare sector continues to be one of the top-performing market sectors. The demand for healthcare products and services only continues to grow. An ageing global population and continuing advances in healthcare treatments and technology are driving this demand.

    Here we examine 2 of my top ASX healthcare shares picks right now: Nanosonics Ltd. (ASX: NAN) and Ansell Limited (ASX: ANN).

    Nanosonics

    Nanosonics manufactures and distributes market-leading disinfection system for ultrasound probes. Its core product is the trophon EPR disinfection system, which has gained industry reputation as the market leader.  The device is fully automated, quick to use and does not require chemicals.

    As well as selling the trophon system product units, the company also sells a range of ancillary products. These recurring consumables grow additional strong revenues over time, in line with the growth of its installed core product unit. This results in a strong combined revenue stream. Nanosonics recorded revenue of $48.5 million for the first half of FY 2020. This was an increase of 19% on the prior corresponding period (pcp).

    The company has strong geographic diversification. Its overseas markets generate 90% of its revenue. Nanosonics continues to grow revenue very strongly in its largest market, the US. It is also seeing strong growth across Asia, Europe and the Middle East.

    Nanosonic’s strategic priorities moving forward focus on 4 core areas. This includes continuing to establish trophon technology as the industry standard in its operating markets. This ASX healthcare share will also look at expanding and investing in new markets.

    Nanosonics could capitalise on the growing global trend towards stricter disinfection control over the next 5–10 years. Globally, more and more health agencies are taking measures to enforce stricter policies to protect against hospital-acquired infections.

    Ansell

    Ansell is involved in the development, manufacturing and sale of gloves and protective personal equipment in the industrial and medical markets. It has broad geographic and customer diversity with sales operations in over 50 countries. Also, most of its new product lines are patentable and must comply with ever-increasing regulatory standards. This further strengthens its competitive position.

    business update in late March revealed a high demand for its hand and body protection products. These products are industry certified for protection against infections such as the coronavirus.

    Ansell is well-positioned to grow over the next decade through rising demand for protective personal equipment in the healthcare segment. 

    Ansell shares are currently trading on a forward dividend yield of 1.9%, unfranked.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Phil Harpur owns shares of Nanosonics Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited. The Motley Fool Australia has recommended Ansell Ltd. and Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Here are 2 quality ASX healthcare shares to buy in July appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2BWU5IG

  • With US Cruise Ship Suspension Extended, Norwegian, Royal Caribbean Analyst Changes Targets

    With US Cruise Ship Suspension Extended, Norwegian, Royal Caribbean Analyst Changes TargetsFollowing an official extension of the suspension of cruise operations from U.S. ports, Norwegian Cruise Line Holdings Ltd (NYSE: NCLH) and Royal Caribbean Cruises Ltd (NYSE: RCL) have halted nearly all cruises through September against expectations of an August resumption, according to BofA Securities.The Cruise Lines Analyst BofA's Andrew Didora updated the estimates to reflect a phased-in recovery beginning in October. The analyst also rolled forward the price targets for cruise lines to 2022 estimates. * Didora maintained a Neutral rating on Norwegian Cruise Line Holdings with a price target lifted from $12.50 to $19. * Didora reiterated an Underperform rating on Royal Caribbean Cruises and raised the price target from $23 to $40.The Cruise Lines Thesis Capacity for cruise lines is likely to remain at just 20% of fourth-quarter 2019 levels and may recover to only 75% in 2021, Didora said in a Wednesday note. (See his track record here.)The analyst lowered 2020 earnings estimates: * From a loss of $7.12 per share to a loss of $7.39 per share for Norwegian Cruise Line Holdings. * From a loss of $14.18 per share to a loss of $15.29 per share for Royal Caribbean Cruises. With the cruise industry not generating any revenue for six months this year, 2021 could be a transition year "as capacity and revenues likely ramp back up slowly throughout the year," the analyst said. NCLH, RCL Price Action Shares of both Norwegian Cruise Line were up 0.19% at $16.45 at the time of publication, while Royal Caribbean shares were higher by 1.01% at $50.82. Related Links: Cruise Stocks Fall After Halting Trips From US PortsCarnival Is Staying Afloat Through 2020, BofA Says After Cruise Line's Preliminary Q2 ReportLatest Ratings for NCLH DateFirmActionFromTo Jun 2020BarclaysDowngradesOverweightEqual-Weight Jun 2020RedburnDowngradesBuyNeutral Jun 2020Morgan StanleyReinstatesUnderweight View More Analyst Ratings for NCLH View the Latest Analyst RatingsSee more from Benzinga * BofA Downgrades iHeartMedia On Lower Visibility, Advertising, Event Headwinds * BofA Raises PG&E Target On Potential Debt Paydown * Cantor Raises Trulieve Cannabis Price Target On Latest Florida Numbers(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/3eRfdyH

  • Cramer Shares His Thoughts On Sirius XM, Nokia And More

    from Yahoo Finance https://ift.tt/31yYlZB

  • Market Recap: Wednesday, July 1

    Market Recap: Wednesday, July 1The S&P 500 and Nasdaq closed higher Wednesday on the news that Pfizer reported positive data on its coronavirus vaccine. However, the Dow closed slightly lower as coronavirus cases continue to spike. The Final Round panel breaks down the details.

    from Yahoo Finance https://ift.tt/2Zx2w5w

  • 5 things to watch on the ASX 200 on Thursday

    Broker trading shares relaxing looking at screen

    On Wednesday the S&P/ASX 200 Index (ASX: XJO) made it two days in a row of solid gains. The benchmark index climbed 0.6% to 5,934.4 points.

    Will the market be able to build on this on Thursday? Here are five things to watch

    ASX 200 expected to push higher.

    It looks set to be another positive day of trade for the ASX 200. According to the latest SPI futures, the benchmark index is poised to rise 40 points or 0.7% at the open. This follows a reasonably positive night of trade on Wall Street. Although the Dow Jones fell 0.3%, the S&P 500 rose 0.5% and the Nasdaq jumped 0.95%. The latter index closed at a record high.

    Pfizer coronavirus vaccine update.

    U.S. markets were given a lift overnight after the release of an update on a study of a coronavirus vaccine candidate. The study of BNT162b1, which is being developed by Pfizer and BioNTech, showed that the drug created neutralising antibodies. However, at this stage the results have not been reviewed by a medical journal. If the vaccine is successful and gets regulatory approval, Pfizer expects to manufacture upwards of 100 million doses by the end of the year.

    Oil prices rebound.

    It could be a good day of trade for energy producers such as Beach Energy Ltd (ASX: BPT) and Oil Search Limited (ASX: OSH) after oil prices jumped higher. According to Bloomberg, the WTI crude oil price is up 1.2% to US$39.73 a barrel and the Brent crude oil price has climbed 1.6% to US$41.92 a barrel. A drawdown in U.S. crude inventories from record highs and some positive manufacturing data supported oil prices.

    Gold price tumbles.

    Gold miners such as Newcrest Mining Limited (ASX: NCM) and Northern Star Resources Ltd (ASX: NST) could come under pressure today after a pullback in the gold price. According to CNBC, the spot gold price has dropped 1.1% to US$1,780.40 an ounce after stronger than expected economic data.

    Webjet raises funds.

    The Webjet Limited (ASX: WEB) share price will be on watch today after the release of a late announcement on Wednesday. The online travel booking company revealed that it is launching an offering of A$163 1 million convertible notes. These notes will be due in 2027.  The company’s Managing Director, John Guscic, commented: “This Offering supports our ongoing focus on maintaining a strong balance sheet as we continue to navigate the challenging operating environment caused by COVID-19.”

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 5 things to watch on the ASX 200 on Thursday appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3dUFjiW

  • Replace your term deposits with these ASX dividend shares

    Young male investor with a pink piggy bank and pile of gold coins

    Fortunately, in this low interest rate environment, there are a good number of dividend shares offering investors generous yields.

    Two dividend shares that I would buy right now instead of a term deposit are listed below. Here’s why I think they are great income options:

    BWP Trust (ASX: BWP)

    As the largest owner of Bunnings Warehouse sites in Australia with 68 leases, I believe BWP could be a property trust to buy. This is because I believe that Bunnings is one of the highest quality businesses in the country and well-positioned to continue its growth through the pandemic and over the coming years. Especially given how the government is supporting the construction industry with renovation grants.

    I believe this should make it easier for BWP to collect rent as normal at a time when other retail property companies are struggling to do so. At present I estimate that the company’s shares offer investors a 4.8% FY 2021 dividend yield.

    Rural Funds Group (ASX: RFF)

    Another property company which I think would be a great option for income investors is Rural Funds. It has a focus on agricultural properties and owns a diverse range of assets across several different industries. These include cattle, vineyards, and orchards. Due to the nature of these industries, its tenants generally sign long term leases. And as these leases tend to contain fixed rental increases, the company has great visibility with its future earnings and distributions.

    As a result, it has already provided its guidance for FY 2021. Next year Rural Funds intends to increase its distribution to 11.28 cents per share. This works out to be a forward 5.6% distribution yield. Overall, I think this makes Rural Funds a great dividend share to own in the current environment.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended RURALFUNDS STAPLED. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Replace your term deposits with these ASX dividend shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3eRTM0j